Publications by authors named "Sigrid Machherndl-Spandl"

Claim this Profile
I
Implementation of a one-tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine.
Karin Deutsch-Biedermann, Katrin Hefler-Frischmuth, Judith Gruber, Christine Kimbacher, Isabella Herbring, Sigrid Machherndl-Spandl

Cytometry B Clin Cytom· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study.
Sonja Wurm, Jennifer M Moritz, Verena Petzer, Dominik Wolf, Karoline V Gleixner, Sigrid Machherndl-Spandl

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of tacrolimus levels on acute GVHD and transplant outcomes in haploidentical hematopoietic stem cell transplantation: A retrospective analysis.
Alexander Nikoloudis, Veronika Buxhofer-Ausch, Ameya Kunte, Christina Groiss, Lorenz Mair, Sigrid Machherndl-Spandl

Cell Transplant· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
Alexander Nikoloudis, Anna Bauhofer, Lena Griessl, Anke Habermehl, Christina Groiss, Sigrid Machherndl-Spandl

Cytotherapy· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful termination of a multi-year wastewater-associated outbreak of NDM-5-carrying E. coli in a hemato-oncological center.
Heidrun Kerschner, Linda Jernej, Adriana Cabal, Patrick Hyden, Sigrid Machherndl-Spandl

Antimicrob Resist Infect Control· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic Leukemia.
Christina Groiss, Stefanie Kreissl, Irene Strassl, Olga Saini, Dagmar Wipplinger, Sigrid Machherndl-Spandl

J Clin Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen-Single-Center Analysis.
Sigrid Machherndl-Spandl, Sarah Hannouf, Alexander Nikoloudis, Otto Zach, Irene Strassl

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study.
Heinz Ludwig, Thomas Melchardt, Ilvy Schweitzer, Siegfried Sormann, Martin Schreder, Sigrid Machherndl-Spandl

EJHaem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of early cyclosporine A levels on acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation using in vivo T-cell depletion.
Alexander Nikoloudis, Veronika Buxhofer-Ausch, Christoph Aichinger, Michaela Binder, Petra Hasengruber, Sigrid Machherndl-Spandl

Cytotherapy· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.
Heinz Ludwig, Thomas Melchardt, Siegfried Sormann, Martin Schreder, Johannes Andel, Sigrid Machherndl-Spandl

Am J Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Baran Khalil, Laura Parzer, Sigrid Machherndl-Spandl, Sophie Haitchi-Petnehazy, Katharina Etmajer

Ophthalmologie· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options-A Single-Center Experience.
Irene Strassl, Alexander Nikoloudis, Sigrid Machherndl-Spandl, Veronika Buxhofer-Ausch, Michaela Binder

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT.
Lisa Pleyer, Marc Vaisband, Manuel Drost, Michael Pfeilstöcker, Reinhard Stauder, Sigrid Machherndl-Spandl

Am J Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.
Karin Bauer, Sigrid Machherndl-Spandl, Lukas Kazianka, Irina Sadovnik, Sinan Gültekin

Leukemia· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Bilateral orbital affection in multiple myeloma].
Baran Khalil, Laura Parzer, Sigrid Machherndl-Spandl, Sophie Haitchi-Petnehazy, Katharina Etmajer

Ophthalmologie· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients-A Retrospective Single-Center Analysis.
Alexander Nikoloudis, Ines Julia Neumann, Veronika Buxhofer-Ausch, Sigrid Machherndl-Spandl, Michaela Binder

Vaccines (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer.
Irene Strassl, Armin Windhager, Sigrid Machherndl-Spandl, Veronika Buxhofer-Ausch, Olga Stiefel

J Cancer Res Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W M Kühn, Sigrid Machherndl-Spandl

Lancet Haematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the Recipient's Pre-Treatment Blood Lymphocyte Count on Intended and Unintended Effects of Anti-T-Lymphocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation.
Alexander Nikoloudis, Veronika Buxhofer-Ausch, Christoph Aichinger, Michaela Binder, Petra Hasengruber, Sigrid Machherndl-Spandl

Cells· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.
Daniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik, Harald Herrmann, Barbara Peter, Sigrid Machherndl-Spandl

Am J Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemia.
Sigrid Machherndl-Spandl, Thomas Vockenhuber, Michaela Binder, Ansgar Weltermann, Petra Apfalter

Leuk Lymphoma· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications.
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Gerald Wulf, Sigrid Machherndl-Spandl

Blood Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multistep pathogenesis of chronic myelomonocytic leukemia in patients.
Klaus Geissler, Eva Jäger, Agnes Barna, Michael Gurbisz, Renate Marschon, Sigrid Machherndl-Spandl

Eur J Haematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group.
Michael Leisch, Michael Pfeilstöcker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Sigrid Machherndl-Spandl

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.
Jelena D Milosevic Feenstra, Roland Jäger, Fiorella Schischlik, Daniel Ivanov, Gregor Eisenwort, Sigrid Machherndl-Spandl

Am J Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis